Progress in the knowledge of the pathophysiology of pain allow to associate
clinical symptoms of painful syndroms to physiological, morphological and
neuro-biochemical changes observed both at peripheral and central sites. Th
us, nociceptive pains involve both a sensitisation of nociceptors and a sec
ondary central sensitisation. Numerous mediators are involved in these phen
omena which reflect neuroplasticity. Peripherally, they come from plasma, i
mmune cells and afferent fibres involved in neurogenic inflammation. Their
number explains how the peripheral mechanisms of pain are complex and how i
t is difficult to pharmacologically suppress the activity of nociceptors. O
ther mediators are involved in the dorsal horn of the spinal cord. Excitato
ry amino acids are particularly involved by acting on NMDA receptors ; subs
tance P seems to work as a facilitatory neuromodulator rather than as a neu
rotransmitter. The mechanisms of neuropathic pains are different because bo
th small and large diameter afferent fibers are involved. Ectopic discharge
s from lesional sites of C fibers, sprouting and abnormal neuronal connecti
ons have been described. Up regulation of ionic, especially sodic, channels
has been demonstrated and could explain spontaneous discharges. Here again
, central sensitisation is also observed but present knowledge does not all
ow to distinguish specific mechanisms.
These progress in the knowledge of pathophysiology of pain allow to improve
the understanding of the mechanism of action of analgesic drugs. They also
give basis to the discover of novel drugs with original mechanisms.